DISCLOSURE POLICY
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as an “ineligible company”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf of all other authors/contributors, if applicable.
Ineligible company: Any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition. |
Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. |
Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship. |
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
For course-specific disclosure listings, please refer to the disclosure insert provided at your course site.
Planning/Development Committee
The following have contributed to the development of the ATLS 10 courses as indicated below:
Kimberly Joseph, MD, FACS (Live Activity, Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Sharon Henry, MD, FACS (Live Activity, Modules)
No relevant financial relationship(s) with ineligible companies to disclose
John Sutyak, MD, FACS (Module)
No relevant financial relationship(s) with ineligible companies to disclose
Joe E. Acker III, MD, FACS (Instructor)
No relevant financial relationship(s) with ineligible companies to disclose
Suresh Agarwal, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Galinos Bamparas, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Karen Brasel, MD, FACS (Live Activity, Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Julie Dunn, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Daniel Grabo, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Oscar Guillamondegui, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Kenji Inaba, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Randeep Jawa, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Dennis Kim, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Stefan Leichtle, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Hunter Moore, MD (Modules)
Founder, Thrombo Therapeutics Incorporated
Deborah Paltridge (Instructor)
No relevant financial relationship(s) with ineligible companies to disclose
Travis Polk, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Justin Regner, MD (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Morgan Schellenberg, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
Kristin Sihler, MD, FACS (Modules)
No relevant financial relationship(s) with ineligible companies to disclose
